StockData
Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc. (XLO) dividend history

XLONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3080% below fair value
$7.54−0.16 (-2.08%)

Close on Nov 17, 2026Market cap $43.60MP/E –Yield –

Dividends

Xilio Therapeutics has not reported a dividend

No dividend per share appears in Xilio Therapeutics's annual filings since fiscal 2019.

See a number that looks wrong?